PH17423A - 3'-substituted-5'-(2-amino-4-pyridyl)1',2'-triazoles - Google Patents

3'-substituted-5'-(2-amino-4-pyridyl)1',2'-triazoles

Info

Publication number
PH17423A
PH17423A PH27793A PH27793A PH17423A PH 17423 A PH17423 A PH 17423A PH 27793 A PH27793 A PH 27793A PH 27793 A PH27793 A PH 27793A PH 17423 A PH17423 A PH 17423A
Authority
PH
Philippines
Prior art keywords
triazoles
pyridyl
amino
substituted
Prior art date
Application number
PH27793A
Other languages
English (en)
Inventor
Christopher Andrew Lipinski
John Lawrence Lamattina
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH17423A publication Critical patent/PH17423A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH27793A 1981-08-31 1982-08-30 3'-substituted-5'-(2-amino-4-pyridyl)1',2'-triazoles PH17423A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29822481A 1981-08-31 1981-08-31

Publications (1)

Publication Number Publication Date
PH17423A true PH17423A (en) 1984-08-08

Family

ID=23149579

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27793A PH17423A (en) 1981-08-31 1982-08-30 3'-substituted-5'-(2-amino-4-pyridyl)1',2'-triazoles

Country Status (19)

Country Link
EP (1) EP0074229B1 (da)
JP (1) JPS5846083A (da)
KR (1) KR860000103B1 (da)
AR (1) AR230994A1 (da)
AT (1) ATE19078T1 (da)
AU (1) AU534063B2 (da)
CA (1) CA1177485A (da)
DE (1) DE3270423D1 (da)
DK (1) DK160303C (da)
ES (1) ES8308324A1 (da)
FI (1) FI78085C (da)
GR (1) GR77241B (da)
HU (1) HU188328B (da)
IE (1) IE53586B1 (da)
IL (1) IL66673A (da)
PH (1) PH17423A (da)
PL (1) PL134315B1 (da)
PT (1) PT75481A (da)
YU (1) YU42795B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004229392A1 (en) 2003-04-09 2004-10-28 Exelixis, Inc. Tie-2 modulators and methods of use
PL2427436T3 (pl) * 2009-05-07 2013-06-28 Gruenenthal Gmbh Podstawione aromatyczne pochodne karboksamidu i mocznika jako ligandy receptora waniloidowego
EP2431035A1 (en) * 2010-09-16 2012-03-21 Æterna Zentaris GmbH Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
WO2021138540A1 (en) 2020-01-03 2021-07-08 Berg Llc Polycyclic amides as ube2k modulators for treating cancer
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276297A (en) * 1979-06-18 1981-06-30 Pfizer Inc. Pyridylaminotriazole therapeutic agents

Also Published As

Publication number Publication date
CA1177485A (en) 1984-11-06
PT75481A (en) 1982-09-01
PL134315B1 (en) 1985-08-31
DK386882A (da) 1983-04-07
IL66673A0 (en) 1982-12-31
FI78085C (fi) 1989-06-12
FI822999A0 (fi) 1982-08-30
EP0074229A1 (en) 1983-03-16
KR860000103B1 (ko) 1986-02-19
FI822999L (fi) 1983-03-01
AU534063B2 (en) 1984-01-05
DE3270423D1 (en) 1986-05-15
IL66673A (en) 1986-04-29
JPS5846083A (ja) 1983-03-17
ATE19078T1 (de) 1986-04-15
KR840001155A (ko) 1984-03-28
IE53586B1 (en) 1988-12-21
HU188328B (en) 1986-04-28
DK160303C (da) 1991-08-05
DK160303B (da) 1991-02-25
ES515366A0 (es) 1983-08-16
PL238095A1 (en) 1984-03-26
YU42795B (en) 1988-12-31
AU8784182A (en) 1983-03-31
ES8308324A1 (es) 1983-08-16
IE822087L (en) 1983-02-28
AR230994A1 (es) 1984-08-31
YU196382A (en) 1985-03-20
EP0074229B1 (en) 1986-04-09
FI78085B (fi) 1989-02-28
GR77241B (da) 1984-09-11

Similar Documents

Publication Publication Date Title
JPS5753490A (en) 5'-aminoalkyl-4',4,8-trialkylpsoralens
GB2106902B (en) 2,2-disubstituted-ethylamines
EP0145023A3 (en) 3, 3", 4" -tri-o-acylspiramycin i
CS604984A2 (en) Zpusob tepelneho stepeni 1,2 dichloretanu
GB2160525B (en) 8,10-dideazaminopterins
GB2140007B (en) 1,8-dihydroxy-10-acyl-9-anthrones
CS620984A2 (en) Zpusob izolace 2-naftylamin-3,6,8-trisulfonove kyseliny
CS770482A2 (en) Zpusob vyroby 1 (3 benzyloxyfenyl) 1,1 dimethylheptanu
IL66673A0 (en) 3'-substituted-5'-(2-amino-4-pyridyl)-1',2',4'-triazoles
GB2125788B (en) 17,18-dehydro-apovincaminol
GB2102429B (en) 9-hydroxy-3-oxo-4,17(20)-pregnadiene-20-carboxaldehyde
GB2105330B (en) Pesticidal 5-phenoxyphenyl-tetrahydro-1,3,5-thiadiazin-4-ones
GB8411250D0 (en) 4,4'-alkylenedipiperidine derivatives
CS378583A1 (en) Sposob vyroby 1,1 azobisformamidu
CS760383A1 (en) Sposob vyroby 1,1 azobisformamidu
CS648483A1 (en) Sposob vyroby 2,2 azobisizobutyronitrilu
CS850684A2 (en) Zpusob vyroby neprasivych chinaxalin 1,4 di n oxidu
CS1024484A2 (en) Zpusob vyroby 3,4,5 trimethoxybenzonitrilu
GB2106513B (en) Imidazo- and pyrimido-1,3,5-thiadiazin-4-ones
GB2098605B (en) 1,3-dihydro-2h-imidazol-2-ones
SU1048747A1 (ru) 9,9-диметил-8,10-динитро-1,6-диазатрицикло[6,3,1,1]
IE810990L (en) 1,2-oxazoles
CS610981A1 (en) Zpusob vyroby derivatu 1 fenyl 1,2,3,4 tetrahydronaftalenu
IE813047L (en) 4, 5-diaryl-ó-(polyhalomethyl)-2-thiophenemethanols
IE813046L (en) 4, 5-diaryl-ó,ó-bis-(polyhalomethyl)-2-thiophenemethanamines